Search Within

Gregory J Riely

  1. "Neuroradiology Service"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (15)
  2. Neuroradiology Service (15)
  3. Radiology, Department of (15)
  4. Solid Tumor Oncology Division (15)
  5. Thoracic Oncology (15)
  6. Biostatistics Service (9)

More Groups

People
  1. Mark Kris (14)
  2. Helena Yu (10)
  3. Alexander Drilon (8)
  4. Robert Young (8)
  5. Michael Offin (6)
  6. Ai Ni (5)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (1)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer (2)
  3. Clinical Cancer Research (2)
  4. JTO Clinical and Research Reports (2)
  5. JAMA Oncology (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (2)
  3. Elsevier BV (2)
  4. Wiley Blackwell (2)
  5. American Medical Association (1)
  6. Elsevier Inc. (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes of de novo brain metastases treated with osimertinib alone in patients with newly diagnosed EGFR-mutant NSCLC
    Journal Article

    Imber, B. S.; Sehgal, R.; Saganty, R.; Reiner, A. S.; Ilica, A. T.; Miao, E.; Li, B. T.; Riely, G. J.; Yu, H. A.; Panageas, K. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • CNS metastases in patients with MET exon 14-altered lung cancers and outcomes with crizotinib
    Journal Article

    Offin, M.; Luo, J.; Guo, R.; Lyo, J. K.; Falcon, C.; Dienstag, J.; Wilkins, O.; Chang, J.; Rudin, C. M.; Riely, G.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Effect of osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: A phase 1/2 single-group open-label trial
    Journal Article

    Yu, H. A.; Schoenfeld, A. J.; Makhnin, A.; Kim, R.; Rizvi, H.; Tsui, D.; Falcon, C.; Houck-Loomis, B.; Meng, F.; Yang, J. L.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • A phase 1/2 study of osimertinib and bevacizumab as initial treatment for patients with metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Kim, R.; Makhnin, A.; Ahn, L. S. H.; Ni, A.; Hayes, S. A.; Young, R. J.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET–rearranged lung cancers
    Journal Article

    Drilon, A.; Lin, J. J.; Filleron, T.; Ni, A.; Milia, J.; Bergagnini, I.; Hatzoglou, V.; Velcheti, V.; Offin, M.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save